Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma
1999

Prognostic Impact of Soluble Cell Adhesion Molecules in Kidney Cancer

Sample size: 99 publication Evidence: moderate

Author Information

Author(s): Hoffmann R, Franzke A, Buer J, Sel S, Oevermann K, Duensing A, Probst M, Duensing S, Kirchner H, Ganser A, Atzpodien J

Primary Institution: Medizinische Hochschule Hannover

Hypothesis

The study aims to determine the prognostic significance of pretreatment serum levels of different molecules involved in cell interactions in patients with metastatic renal cell carcinoma.

Conclusion

The study found that higher levels of sICAM-1, along with other clinical parameters, are significant predictors of overall patient survival in metastatic renal cell carcinoma.

Supporting Evidence

  • Serum sICAM-1 levels greater than 360 ng/ml were identified as a risk factor for poor survival.
  • Multivariate analyses showed that sICAM-1, ESR, and CRP are independent predictors of survival.

Takeaway

Doctors can use certain blood markers to help predict how well patients with kidney cancer might do after treatment.

Methodology

Serum levels of sICAM-1, sVCAM-1, and sELAM-1 were measured using ELISA in patients with metastatic renal cell carcinoma, followed by survival analysis and regression analyses.

Participant Demographics

Patients with histologically confirmed progressive metastatic renal cell carcinoma.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690277

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication